| - GRCh37:
- Chr19:46087983
- GRCh38:
- Chr19:45584725
| OPA3 | L14V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056854
- GRCh38:
- Chr19:45553596
| OPA3 | R153L | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056888-46056889
- GRCh38:
- Chr19:45553630-45553631
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087989
- GRCh38:
- Chr19:45584731
| OPA3 | L12V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057023
- GRCh38:
- Chr19:45553765
| OPA3 | L97V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087908
- GRCh38:
- Chr19:45584650
| OPA3 | T39A | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057160
- GRCh38:
- Chr19:45553902
| OPA3 | W51* | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely pathogenic (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056875
- GRCh38:
- Chr19:45553617
| OPA3 | Q146R | 3-Methylglutaconic aciduria type 3, Optic atrophy 3, Inborn genetic diseases
| Uncertain significance (Oct 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:46087999
- GRCh38:
- Chr19:45584741
| OPA3 | M8I | Inborn genetic diseases, 3-Methylglutaconic aciduria type 3, Optic atrophy 3
| Uncertain significance (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:46087861
- GRCh38:
- Chr19:45584603
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057087
- GRCh38:
- Chr19:45553829
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056960
- GRCh38:
- Chr19:45553702
| OPA3 | A118P | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056895
- GRCh38:
- Chr19:45553637
| OPA3 | Q139H | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057092
- GRCh38:
- Chr19:45553834
| OPA3 | E74* | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087902
- GRCh38:
- Chr19:45584644
| OPA3 | I41V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057186
- GRCh38:
- Chr19:45553928
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056975
- GRCh38:
- Chr19:45553717
| OPA3 | E113K | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056864
- GRCh38:
- Chr19:45553606
| OPA3 | E150Q | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057102
- GRCh38:
- Chr19:45553844
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087978
- GRCh38:
- Chr19:45584720
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056878
- GRCh38:
- Chr19:45553620
| OPA3 | P145L | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056952
- GRCh38:
- Chr19:45553694
| OPA3 | N120K | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056799
- GRCh38:
- Chr19:45553541
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087920
- GRCh38:
- Chr19:45584662
| OPA3 | E35* | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Pathogenic (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057065
- GRCh38:
- Chr19:45553807
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056939
- GRCh38:
- Chr19:45553681
| OPA3 | E125Q | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jul 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087939
- GRCh38:
- Chr19:45584681
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057084
- GRCh38:
- Chr19:45553826
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087891
- GRCh38:
- Chr19:45584633
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056932
- GRCh38:
- Chr19:45553674
| OPA3 | G127D | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46088008
- GRCh38:
- Chr19:45584750
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087934
- GRCh38:
- Chr19:45584676
| OPA3 | A30V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087887
- GRCh38:
- Chr19:45584629
| OPA3 | A46T | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056970
- GRCh38:
- Chr19:45553712
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056835
- GRCh38:
- Chr19:45553577
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056828
- GRCh38:
- Chr19:45553570
| OPA3 | Q162* | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057008
- GRCh38:
- Chr19:45553750
| OPA3 | W102G | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056857
- GRCh38:
- Chr19:45553599
| OPA3 | L152P | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087998
- GRCh38:
- Chr19:45584740
| OPA3 | A9T | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056818
- GRCh38:
- Chr19:45553560
| OPA3 | N165S | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057074
- GRCh38:
- Chr19:45553816
| OPA3 | G80S | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057178
- GRCh38:
- Chr19:45553920
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057108
- GRCh38:
- Chr19:45553850
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056948
- GRCh38:
- Chr19:45553690
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057173
- GRCh38:
- Chr19:45553915
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056850
- GRCh38:
- Chr19:45553592
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056835
- GRCh38:
- Chr19:45553577
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057059
- GRCh38:
- Chr19:45553801
| OPA3 | G85R | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jul 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057117
- GRCh38:
- Chr19:45553859
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056882-46056883
- GRCh38:
- Chr19:45553624-45553625
| OPA3 | P144T | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056795
- GRCh38:
- Chr19:45553537
| OPA3 | A173T | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056876
- GRCh38:
- Chr19:45553618
| OPA3 | Q146K | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057068
- GRCh38:
- Chr19:45553810
| OPA3 | E82* | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056920
- GRCh38:
- Chr19:45553662
| OPA3 | L131Q | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057147
- GRCh38:
- Chr19:45553889
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087912
- GRCh38:
- Chr19:45584654
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057047
- GRCh38:
- Chr19:45553789
| OPA3 | I89V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056938
- GRCh38:
- Chr19:45553680
| OPA3 | E125V | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056843
- GRCh38:
- Chr19:45553585
| OPA3 | Q157E | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087942
- GRCh38:
- Chr19:45584684
| OPA3 | K28fs | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056840
- GRCh38:
- Chr19:45553582
| OPA3 | E158K | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087868
- GRCh38:
- Chr19:45584610
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056926-46056927
- GRCh38:
- Chr19:45553668-45553669
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087929
- GRCh38:
- Chr19:45584671
| OPA3 | R32C | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057111
- GRCh38:
- Chr19:45553853
| OPA3 | I68fs | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057170
- GRCh38:
- Chr19:45553912
| OPA3 | | 3-Methylglutaconic aciduria type 3 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057170-46088123
| OPA3 | | 3-Methylglutaconic aciduria type 3 | Likely pathogenic (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087993
- GRCh38:
- Chr19:45584735
| OPA3 | K10N | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057100
- GRCh38:
- Chr19:45553842
| OPA3 | L71P | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087932
- GRCh38:
- Chr19:45584674
| OPA3 | A31P | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087950
- GRCh38:
- Chr19:45584692
| OPA3 | N25D | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056881
- GRCh38:
- Chr19:45553623
| OPA3 | P144R | 3-Methylglutaconic aciduria type 3, Optic atrophy 3, Optic atrophy 3
| Uncertain significance (Feb 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:46057177
- GRCh38:
- Chr19:45553919
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056781
- GRCh38:
- Chr19:45553523
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (May 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087993
- GRCh38:
- Chr19:45584735
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jan 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056859
- GRCh38:
- Chr19:45553601
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jun 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057077
- GRCh38:
- Chr19:45553819
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056949
- GRCh38:
- Chr19:45553691
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087863
- GRCh38:
- Chr19:45584605
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Dec 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057168
- GRCh38:
- Chr19:45553910
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Apr 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056850
- GRCh38:
- Chr19:45553592
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056979
- GRCh38:
- Chr19:45553721
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057075
- GRCh38:
- Chr19:45553817
| OPA3 | | Optic atrophy 3, 3-Methylglutaconic aciduria type 3 | Likely benign (Mar 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056796
- GRCh38:
- Chr19:45553538
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087865
- GRCh38:
- Chr19:45584607
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056871
- GRCh38:
- Chr19:45553613
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087871
- GRCh38:
- Chr19:45584613
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056805
- GRCh38:
- Chr19:45553547
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Nov 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057030
- GRCh38:
- Chr19:45553772
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057057
- GRCh38:
- Chr19:45553799
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056961
- GRCh38:
- Chr19:45553703
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057178
- GRCh38:
- Chr19:45553920
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056886
- GRCh38:
- Chr19:45553628
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Nov 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056949
- GRCh38:
- Chr19:45553691
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Aug 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46056985
- GRCh38:
- Chr19:45553727
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Nov 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087951
- GRCh38:
- Chr19:45584693
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46088017
- GRCh38:
- Chr19:45584759
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057009
- GRCh38:
- Chr19:45553751
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Dec 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46057066
- GRCh38:
- Chr19:45553808
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr19:46087983
- GRCh38:
- Chr19:45584725
| OPA3 | | 3-Methylglutaconic aciduria type 3, Optic atrophy 3 | Likely benign (Sep 1, 2021) | criteria provided, single submitter |